This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Study of LY2409021 in Participants With Type 2 D...
Clinical trial

A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus

Read time: 1 mins
Last updated:8th Apr 2014

The intent of this study is to assess the safety of LY2409021 in participants with Type 2 diabetes mellitus taking metformin and sulfonylurea as prescribed by their personal physician. The study treatment is expected to last 12 months (52 weeks).

Category Value
Study start date 2014-04-08

View full details